January 2005
Taber's Cyclopedic Medical Dictionary;2005, p1800
Reference Entry
The article presents a definition of the term "PSA." It refers to prostate-specific antigen.


Related Articles

  • biomarker.  // Taber's Cyclopedic Medical Dictionary;2005, p247 

    A definition of the medical term "biomarker" is presented. Biomarker refers to a signal that serves as an indicator of the state of a living organism. It is a biochemical, genetic, or molecular indicator that can be used to screen diseases, such as cancer. The definition is from the "Taber's...

  • Radiation for prostate cancer: use of biochemical failure as an endpoint following radiotherapy. Kuban, Deborah A.; Thames, Howard D.; Levy, Larry B. // World Journal of Urology;Sep2003, Vol. 21 Issue 4, p253 

    The introduction of prostate-specific antigen (PSA) as a reliable tumor marker for prostate cancer brought significant changes in endpoints after therapy and in outcome reporting. Over the last 15 years we have collected follow-up information in this new era and struggled with failure...

  • PSA standardization: Making sense of the controversy. Vignati, Giulio // Urology Times;3/1/2009, Vol. 37 Issue 3, p24 

    The article offers information on the restandardization on Prostate-Specific Antigen (PSA) serum biomarker. It notes that the problem on the standardization in PSA exists, however, Equimolarity and WHO calibration have contributed to enhance PSA results harmonization. It notes that PSA attempts...

  • neoantigen.  // Taber's Cyclopedic Medical Dictionary;2005, p1438 

    A definition of the medical term "neoantigen" is presented, which refers to a nonspecific term for various tumor antigens. The definition is from the "Taber's Cyclopedic Medical Dictionary," published by F.A. Davis Co.

  • JARGON BUSTER. MATILDA ELLIS // Daily Mail;11/19/2013, p39 

    MEDICAL terms decoded. This week: Biomarker IN MEDICINE a biomarker is a molecule, gene or characteristic that is linked to a particular disease or condition, or physical state.

  • PCA3 and TMPRSS2-ERG: Promising Biomarkers in Prostate Cancer Diagnosis. Salagierski, Maciej; Schalken, Jack A. // Cancers;2010, Vol. 2 Issue 3, p1432 

    The search for the biomarkers to precisely and non-invasively characterize the biology of prostate cancer (PCa) is the focus of many laboratories across the world. Although prostate-specific antigen (PSA) remains the standard diagnostic tool for PCa, its low specificity leads to unnecessary...

  • Pathology Consultation on Prostate-Specific Antigen Testing. Noguez, Jaime H.; Fantz, Corinne R. // American Journal of Clinical Pathology;Jul2014, Vol. 142 Issue 1, p7 

    Objectives: To provide clarity on the pros and cons of using prostate-specific antigen (PSA) as a screening tool for prostate cancer. Methods: Case scenarios and a literature review of recently published clinical trial data are presented to provide evidence of the controversy. Results: PSA is a...

  • No Proof Yet For the PSA Test.  // HealthFacts;Oct2002, Vol. 27 Issue 10, p2 

    Presents an update on issues related to prostate-specific antigen test in the U.S. as of October 2002.

  • Could PSA Screening Be Harmful? New Guidelines Available. Gupta, Rahul // Internal Medicine Alert;9/15/2008, Vol. 30 Issue 17, p329 

    The article underscores that prostate-specific antigen (PSA) screening may be related with psychological harms and that there has been update to the screening guidelines conducted by the U. S. Preventive Services Task Force (USPSTF).


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics